HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,405,974 | +21.7% | 60,348 | +15.7% | 0.01% | +12.5% |
Q2 2023 | $4,440,562 | -59.8% | 52,156 | -60.9% | 0.01% | -60.0% |
Q1 2023 | $11,040,836 | +12.4% | 133,424 | +6.8% | 0.02% | +5.3% |
Q4 2022 | $9,824,565 | +203.1% | 124,915 | +185.3% | 0.02% | +171.4% |
Q3 2022 | $3,241,000 | -39.3% | 43,778 | -42.1% | 0.01% | +75.0% |
Q3 2021 | $5,341,000 | +7.7% | 75,654 | +1.7% | 0.00% | 0.0% |
Q2 2021 | $4,957,000 | -40.0% | 74,384 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $8,257,000 | -55.1% | 74,384 | -51.9% | 0.01% | -55.6% |
Q4 2020 | $18,380,000 | +28.7% | 154,778 | -5.4% | 0.02% | +5.9% |
Q3 2020 | $14,281,000 | -19.8% | 163,688 | -17.6% | 0.02% | -19.0% |
Q2 2020 | $17,802,000 | -3.4% | 198,770 | +7.5% | 0.02% | -16.0% |
Q1 2020 | $18,430,000 | -16.4% | 184,923 | -3.6% | 0.02% | +25.0% |
Q4 2019 | $22,036,000 | +3.1% | 191,786 | +13.2% | 0.02% | -4.8% |
Q3 2019 | $21,372,000 | +16.0% | 169,431 | +10.7% | 0.02% | +23.5% |
Q2 2019 | $18,418,000 | +58.5% | 153,050 | +15.2% | 0.02% | +41.7% |
Q1 2019 | $11,617,000 | -7.5% | 132,799 | +5.8% | 0.01% | -14.3% |
Q4 2018 | $12,553,000 | -16.4% | 125,470 | -4.2% | 0.01% | 0.0% |
Q3 2018 | $15,008,000 | +25.6% | 130,988 | -1.7% | 0.01% | +16.7% |
Q2 2018 | $11,952,000 | +43.8% | 133,272 | +17.3% | 0.01% | +50.0% |
Q1 2018 | $8,313,000 | – | 113,630 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |